Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

antimicrobial stewardship; pharmacy; sepsis; wound management; culture and sensitivity testing; resistance patterns; low-and middle-income countries; Uganda; antibiotic; antimicrobial resistance; veterinary; animal health; Africa; bone infection; joint infection; osteomyelitis; pediatric infectious disease; septic arthritis; antibiotics; microbial resistance; upper respiratory tract infections; fosfomycin; urinary infection; resistance; CwPAMS App; smartphone apps; antimicrobial prescribing; low- and middle-income countries; barriers and enablers; training; antibiotics use; behavior change; Helicobacter pylori; therapy; metronidazole; clarithromycin; fluoroquinolones; amoxicillin; proton pump inhibitors; ethical trials; obesity; bloodstream infection; antimicrobials; prescription; community health workers; health practitioners; infection prevention and control; multidisciplinary; one health; UK; antimicrobial resistance (AMR); antimicrobial stewardship (AMS); delayed/back-up prescribing; developing countries; LMICs; Ghana; knowledge; attitudes; medical students; antimicrobial; stewardship; prescribing; meningitis; encephalitis; FilmArray; multiplex PCR; rapid diagnostic technology; children; adolescents; outcomes; antibiotic stewardship program; complementarity; prospective audit and feedback; antibiotic stewardship; pharyngitis; acute otitis media; clinical pathways; emergency departments; antibiotic use; prescribing appropriateness; follow-up blood cultures; Gram negative bacteremia; critically ill patients; antibiotic therapy; general practice; family practice; health policy; quality of health care; public health; pharmacist; nurse; COVID-19; antibiotic resistance; wound care; burn care; Nepal; AMS; antimicrobial stewardship intervention; PDSA cycle; enterococcal; bacteremia; epidemiology; risk factors; mortality; urinary tract infections (UTI); older adults; qualitative; leaflet; Theoretical Domains Framework; coronavirus; SARS-CoV-2; anti-infective agents; candidemia; hematologic diseases; complex intervention